サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1422990

ワクチンバイアル市場：レポートタイプ、材料、容量、用途、地域別、2024年～2032年

Vaccine Vials Market by Report Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity (10ml, 20ml, 2ml, 3ml, 5ml), Application (Preventive Vaccine, Therapeutic Vaccine), and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ワクチンバイアル市場：レポートタイプ、材料、容量、用途、地域別、2024年～2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のワクチンバイアル市場規模は2023年に6億3,810万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに14億1,700万米ドルに達し、2024年から2032年の間に8.99%の成長率（CAGR）を示すと予測しています。感染症の流行の増加、著しい技術革新、新しいワクチンの開発、世界人口の着実な増加、厳格な品質管理対策などが市場を推進している主な要因です。

ワクチンバイアルは、無菌環境でワクチンを保管するために設計された特殊なガラス製またはプラスチック製の容器です。これらのバイアルは、厳格な品質・安全基準を満たすように細心の注意を払って作られており、ワクチンの効力、有効性、安定性が保管・輸送中も維持されるようになっています。一般的に、ワクチンバイアルには密封キャップまたはストッパーが付いており、ワクチンを抽出するためにシリンジで穴を開けることができます。バイアルには、ワクチンの種類や使用上の要件に応じて、1回分または複数回分を入れることができます。バイアルに使用される材料は、ワクチンと相互作用しないことを確認するため、多くの場合、厳格な試験を受け、その完全性が保たれます。

感染症の流行が増加していることは、世界全体の市場成長を促進する主な要因の1つです。このことは、予防接種プログラムへの関心の高まりと相まって、大きな成長促進要因として作用しています。このため、ワクチンの保管や流通を容易にするワクチンバイアルに対する安定した需要が生まれています。市場はまた、ワクチンの保存期間と安定性を強化することを目的とした、バイアルの材料と設計における技術革新によっても牽引されています。規制ガイドラインもまた、より厳格な品質管理措置や無菌要件によって重要な役割を果たしており、これがメーカーに高品質のバイアルを製造するよう影響を与えています。WHO、GAVI、Vaccine Alliance、各国の保健省などの組織によるワクチン接種キャンペーンなどのヘルスケアイニシアチブの高まりは、ワクチンバイアルの必要性に拍車をかけています。人口増加や病気にかかりやすくなる高齢化などの人口統計学的要因も、需要をさらに高めています。さらに、流通ロジスティクスとコールドチェーン管理の進歩により、より効果的で広範囲なワクチン流通が可能になり、これが間接的に世界全体の市場を牽引しています。

ワクチンバイアル市場の動向と促進要因：

健康への取り組みと予防接種プログラムの増加

予防接種プログラムの重視の高まりは、市場の最も重要な促進要因の一つです。世界保健機関（WHO）やGaviなどの組織や各国政府は、感染症の撲滅や制圧を目的としたワクチン接種キャンペーンに多額の投資を行っています。こうしたイニシアチブは、ワクチンの安全な保管、輸送、配送に不可欠なワクチンバイアルの高い需要を生み出しています。さらに、COVID-19パンデミックのような新たな感染症の発生は、緊急かつ大規模な予防接種の取り組みをもたらし、ワクチンバイアル市場にさらなる需要圧力をかけています。

材料とデザインにおける大幅な技術進歩

ワクチンバイアルに使用される設計と材料における技術革新は、市場成長を促進するもう一つの重要な要因です。破損、汚染、ワクチンの有効成分との相互作用に対してより耐性がある高度なガラスやポリマー材料が開発されています。これらの技術革新は、ワクチンの安全性と有効性を高めるだけでなく、保存期間を延長することで、特に遠隔地においてワクチンをより利用しやすくしています。

規制遵守と品質保証の高まり

ワクチンの保管や輸送に関する厳しい規制も、高品質のワクチンバイアルの必要性を高めています。規制機関は、厳格な品質管理と無菌性の要件を課しており、メーカーがこれらの基準を満たすか上回るバイアルを製造するよう影響を及ぼしています。品質保証を重視することで、ワクチンを最適な状態で保管し、有効性を維持し、腐敗による廃棄物を最小限に抑えることができます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のワクチンバイアル市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • マルチ投与
    • 市場動向
    • 市場予測
  • シングル投与
    • 市場動向
    • 市場予測

第7章 市場内訳：素材別

  • ガラス
    • 市場動向
    • 市場予測
  • ポリマー
    • 市場動向
    • 市場予測

第8章 市場内訳：容量別

  • 10ml
    • 市場動向
    • 市場予測
  • 20ml
    • 市場動向
    • 市場予測
  • 2ml
    • 市場動向
    • 市場予測
  • 3ml
    • 市場動向
    • 市場予測
  • 5ml
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • 予防ワクチン
    • 市場動向
    • 市場予測
  • 治療用ワクチン
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Anhui Huaxin Medicinal Glass Products Co. Ltd.
    • Berlin Packaging LLC
    • Corning Incorporated
    • DWK Life Sciences GmbH
    • Gerresheimer AG
    • Jinan Youlyy Industrial Co. Ltd.
    • JOTOP Glass
    • Richland Glass Company
    • Schott AG
    • Shandong Pharmaceutical Glass Co. Ltd.
    • Stevanato Group
図表

List of Figures

  • Figure 1: Global: Vaccine Vials Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Vials Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Vaccine Vials Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Vaccine Vials Market: Breakup by Material (in %), 2023
  • Figure 6: Global: Vaccine Vials Market: Breakup by Capacity (in %), 2023
  • Figure 7: Global: Vaccine Vials Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Vaccine Vials Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Vaccine Vials (Multi Dose) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Vaccine Vials (Multi Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Vaccine Vials (Single Dose) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Vaccine Vials (Single Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Vaccine Vials (Glass) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Vaccine Vials (Glass) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Vaccine Vials (Polymer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Vaccine Vials (Polymer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Vaccine Vials (10ml) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Vaccine Vials (10ml) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Vaccine Vials (20ml) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Vaccine Vials (20ml) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Vaccine Vials (2ml) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Vaccine Vials (2ml) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Vaccine Vials (3ml) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Vaccine Vials (3ml) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Vaccine Vials (5ml) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Vaccine Vials (5ml) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Vaccine Vials (Preventive Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Vaccine Vials (Preventive Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Vaccine Vials (Therapeutic Vaccine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Vaccine Vials (Therapeutic Vaccine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Vaccine Vials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Vaccine Vials Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Vaccine Vials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Vaccine Vials Industry: SWOT Analysis
  • Figure 81: Global: Vaccine Vials Industry: Value Chain Analysis
  • Figure 82: Global: Vaccine Vials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Vials Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Vaccine Vials Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Vaccine Vials Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Vaccine Vials Market Forecast: Breakup by Capacity (in Million US$), 2024-2032
  • Table 5: Global: Vaccine Vials Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Vaccine Vials Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Vaccine Vials Market: Competitive Structure
  • Table 8: Global: Vaccine Vials Market: Key Players
目次
Product Code: SR112024A6599

Abstract

The global vaccine vials market size reached US$ 638.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,417.0 Million by 2032, exhibiting a growth rate (CAGR) of 8.99% during 2024-2032. The increasing prevalence of infectious diseases, significant technological innovations, the development of new vaccines, the steadily increasing global population, and strict quality control measures are some of the major factors propelling the market.

Vaccine vials are specialized glass or plastic containers designed to store vaccines in a sterile environment. These vials are meticulously crafted to meet strict quality and safety standards, ensuring that the vaccine's potency, efficacy, and stability are maintained during storage and transportation. Generally, vaccine vials come with a sealed cap or stopper that can be punctured by a syringe for vaccine extraction, thus ensuring a closed system that minimizes contamination risks. They can contain either single-dose or multi-dose quantities, depending on the type and usage requirements of the vaccine. The material used for the vials is often subjected to rigorous testing to ensure it does not interact with the vaccine, preserving its integrity.

The increasing prevalence of infectious diseases represents one of the key factors driving the growth of the market across the globe. This, coupled with the rising focus on immunization programs is acting as a major growth-inducing factor. This creates a consistent demand for vaccine vials to facilitate the storage and distribution of vaccines. The market is also driven by technological innovation in vial materials and design, aimed at enhancing the shelf-life and stability of vaccines. Regulatory guidelines also play a crucial role with stricter quality control measures and sterility requirements which are influencing manufacturers to produce high-quality vials. The rising healthcare initiatives, such as vaccination campaigns by organizations like the WHO, GAVI, the Vaccine Alliance, and national health departments of various countries, are fueling the need for vaccine vials. Demographic factors, including population growth and an aging population more susceptible to diseases, are adding another layer of demand. Moreover, advancements in distribution logistics and cold chain management allow for more effective and far-reaching vaccine distribution, which is indirectly driving the market across the globe.

Vaccine Vials Market Trends/Drivers:

Rising health initiatives and immunization programs

The growing emphasis on immunization programs is one of the most significant drivers in the market. Organizations, such as the World Health Organization (WHO) and Gavi, as well as national governments, are investing heavily in vaccination campaigns to eradicate or control infectious diseases. These initiatives generate a high demand for vaccine vials as they are essential for the safe storage, transportation, and delivery of vaccines. Furthermore, outbreaks of new infectious diseases, such as the COVID-19 pandemic, result in urgent, large-scale immunization efforts, putting additional demand pressure on the vaccine vials market.

Significant technological advancements in material and design

Innovations in the design and materials used for vaccine vials is another key factor driving the market growth. Advanced glass and polymer materials that are more resistant to breakage, contamination, and interaction with the vaccine's active ingredients are being developed. These innovations not only enhance the safety and efficacy of vaccines but also extend their shelf life, thus making vaccines more accessible, particularly in remote areas.

Rise in regulatory compliance and quality assurance

Stringent regulations regarding vaccine storage and transportation also drive the need for high-quality vaccine vials. Regulatory bodies are imposing rigorous quality control and sterility requirements, which is influencing manufacturers to produce vials that meet or exceed these standards. The emphasis on quality assurance ensures that vaccines are stored in optimal conditions, preserving their effectiveness, and minimizing waste due to spoilage.

Vaccine Vials Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global vaccine vials market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on type, material, capacity, and application.

Breakup by Type:

Multi Dose

Single Dose

Multi dose represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the type. This includes multi dose and single dose. According to the report, multi dose represented the largest segment.

Multi-dose vials are generally more cost-efficient than single-dose vials as they utilize less packaging material and occupy less storage space. This makes them economically attractive, particularly for large-scale immunization programs. In situations where mass vaccination is required, such as pandemic response or routine immunization programs, multi-dose vials allow for the quick and efficient vaccination of many individuals. This is especially relevant in low-resource settings where rapid administration is crucial. Multi-dose vials are easier to transport and store, which is particularly important in regions with limited cold chain infrastructure. Their compact size and lesser weight compared to an equivalent number of single-dose vials make them more manageable in logistics operations. Utilizing multi-dose vials can reduce medical waste, as fewer vials are needed to deliver the same number of doses. This is an attractive feature from an environmental sustainability perspective. Many health organizations advocate for the use of multi-dose vials under controlled conditions to extend the reach of vaccination programs, thereby driving demand.

Breakup by Material:

Glass

Polymer

Glass represents the largest market segment

A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes glass and polymer. According to the report, glass accounted for the largest market share.

The widespread adoption of glass as a primary material in the vaccine vials market is underpinned by several influential factors that underscore its prominence. Foremost is the material's exceptional compatibility with pharmaceutical products, ensuring the preservation of vaccine integrity and efficacy. Glass offers an inert and non-reactive environment, preventing chemical interactions that could compromise the vaccine's composition. The impermeability of glass to gases and moisture safeguards against contamination, maintaining the sterile conditions vital for vaccine stability. Additionally, glass vials are amenable to aseptic filling processes, minimizing the risk of microbial intrusion. The transparency of glass aids in accurate dosage measurement and visual inspection of contents. Furthermore, glass is recyclable and environmentally responsible, aligning with sustainability objectives.

Breakup by Capacity:

10ml

20ml

2ml

3ml

5ml

A detailed breakup and analysis of the market based on capacity has also been provided in the report. This includes 10ml, 20ml, 2ml, 3ml, and 5ml.

The vaccine vials market segmentation based on 10ml capacity addresses the need for efficient storage and administration of vaccines that require larger doses. These vials are ideal for multi-dose vaccines and mass immunization campaigns, as they allow for precise dosage measurement and reduced wastage. The 10ml capacity segment caters to healthcare scenarios where accurate dosing, ease of distribution, and optimized resource utilization are pivotal. This segmentation ensures that vaccines with higher dosage requirements can be effectively stored, transported, and administered, thus contributing to streamlined vaccination efforts and effective public health outcomes.

Based on 20ml capacity, the vaccine vials market segmentation addresses the demand for efficient storage and administration of vaccines requiring larger doses. These vials are suitable for multi-dose vaccines and mass vaccination campaigns, ensuring precise dosing and minimizing wastage. The 20ml capacity segment meets healthcare needs where accurate dosing, streamlined distribution, and optimal resource usage are essential. This segmentation facilitates the storage, transportation, and dispensing of vaccines with higher dosage requirements, thus contributing to effective immunization initiatives and public health outcomes.

On the basis of 2ml capacity, the vaccine vials market segmentation addresses the demand for precise dosing and efficient administration of vaccines with smaller doses. These vials are well-suited for single-dose vaccines and pediatric applications, ensuring accurate dosage measurement and minimal wastage. The 2ml capacity segment caters to scenarios where precise dosing, ease of use, and minimizing contamination risks are critical. This segmentation facilitates the storage, transportation, and delivery of vaccines requiring smaller doses, which contributes to effective immunization strategies and healthcare outcomes, particularly for vulnerable populations such as children.

The vaccine vials market segmentation based on 3ml capacity caters to the need for accurate dosing and efficient delivery of vaccines requiring moderate-sized doses. These vials are suitable for single-dose vaccines and applications where precise measurement is crucial. The 3ml capacity segment addresses healthcare scenarios that demand reliable dosing, convenient handling, and reduced risk of contamination. This segmentation facilitates the storage, transportation, and administration of vaccines with intermediate dosage requirements, thereby contributing to effective immunization strategies and healthcare outcomes for various patient populations.

Based on 5ml capacity, the vaccine vials market segmentation caters to the versatility of vaccine dosing requirements. These vials accommodate a range of vaccine formulations and dosages, thus making them suitable for various applications, including routine immunizations and special campaigns. The 5ml capacity segment is chosen in scenarios where flexibility, efficient storage, and streamlined distribution are essential. This segmentation allows for the storage, transportation, and precise administration of vaccines with diverse dosage needs, which contributes to effective vaccination efforts and healthcare outcomes for different patient populations.

Breakup by Application:

Preventive Vaccine

Therapeutic Vaccine

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes preventive vaccine and therapeutic vaccine.

Preventive vaccines are designed to proactively protect individuals from infectious diseases by stimulating the immune system to develop immunity against specific pathogens. Preventive vaccines target a wide array of diseases, ranging from common childhood illnesses like measles, mumps, and rubella to more complex diseases, such as influenza and human papillomavirus. The use of vaccine vials in this context is pivotal, ensuring that the vaccines remain stable, effective, and ready for administration when needed. The market's segmentation based on preventive vaccines considers the diverse spectrum of immunization needs and their critical role in preventing the spread of communicable diseases. Preventive vaccines play a pivotal role in reducing the burden of infectious diseases and curbing epidemics. The availability of vaccine vials tailored to their specific dosing needs contributes to accurate dosing, streamlined distribution, and effective immunization campaigns.

Therapeutic vaccines are administered after a person has already contracted a disease. These vaccines aim to modulate the immune response and assist the body in fighting the disease more effectively. Therapeutic vaccines are developed for diseases like cancer, where the immune system's response is directed towards eliminating cancerous cells. The application of vaccine vials in the therapeutic context emphasizes the importance of maintaining vaccine integrity, stability, and dosing precision to ensure that the therapeutic effects are optimized. Therapeutic vaccines are less common than preventive vaccines and offer promise in addressing various medical challenges. The use of vaccine vials in this context is essential for ensuring the appropriate storage and administration of these specialized treatments. The ability to deliver therapeutic vaccines accurately and reliably is critical in achieving desired therapeutic outcomes.

Breakup by Region:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America accounted for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

In North America, the vaccine vials market is significantly influenced by several key factors. Primarily, the robust healthcare infrastructure and a strong emphasis on immunization programs in the region are creating consistent demand for high-quality vaccine vials. Technological innovation is a major driver, with companies investing in research and development (R&D) to produce advanced vial materials and designs that enhance vaccine storage and longevity. Regulatory compliance also plays a crucial role with strict FDA guidelines on vaccine storage requiring vials that meet high-quality standards, further driving the market. The presence of major pharmaceutical companies and frequent launches of new vaccines contribute to the steady growth of the vaccine vials market in North America.

Competitive Landscape:

Key market players in the vaccine vials market are actively engaged in various strategies to strengthen their market position. One predominant focus is on research and development (R&D) to create advanced vial materials and designs that enhance vaccine preservation and usability. Companies are increasingly adopting materials like borosilicate glass and high-grade plastics that are less prone to interaction with the vaccine, ensuring potency and stability over extended periods. Many companies are entering into partnerships or acquisitions to bolster their manufacturing capacities and geographic reach. Quality assurance remains a critical area of investment, with companies intensifying their efforts to comply with stringent regulatory standards for sterility and durability. Automation in quality checks is also being adopted for higher efficiency and consistency. Additionally, key players are actively participating in global healthcare initiatives and are collaborating with organizations and governments to provide vials for large-scale vaccination programs. Companies are focusing on sustainability by exploring eco-friendly materials and recycling programs, acknowledging the environmental impact of vial production.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Anhui Huaxin Medicinal Glass Products Co. Ltd.

Berlin Packaging LLC

Corning Incorporated

DWK Life Sciences GmbH

Gerresheimer AG

Jinan Youlyy Industrial Co. Ltd.

JOTOP Glass

Richland Glass Company

Schott AG

Shandong Pharmaceutical Glass Co. Ltd.

Stevanato Group.

Recent Developments:

In October 2022, GSK plc announced the US Food and Drug Administration (FDA) approved a new presentation of Menveo [Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diptheria CRM197 Conjugate Vaccine] for individuals aged 10 to 55 years to help prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W.

In September 2022, BD (Becton, Dickinson and Company), a leading global medical technology company, introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity.

In July 2021, Italy's Stevanato Group S.p.A. (STVN.N) made a tepid debut on the New York Stock Exchange as its shares slid, by giving the world's second-largest glass vial maker a valuation of $5 billion.

Key Questions Answered in This Report

  • 1. What was the size of the global vaccine vials market in 2023?
  • 2. What is the expected growth rate of the global vaccine vials market during 2024-2032
  • 3. What are the key factors driving the global vaccine vials market?
  • 4. What has been the impact of COVID-19 on the global vaccine vials market?
  • 5. What is the breakup of the global vaccine vials market based on the type?
  • 6. What is the breakup of the global vaccine vials market based on the material?
  • 7. What are the key regions in the global vaccine vials market?
  • 8. Who are the key players/companies in the global vaccine vials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Vials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Multi Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Single Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Glass
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Capacity

  • 8.1 10ml
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 20ml
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 2ml
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 3ml
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 5ml
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Preventive Vaccine
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutic Vaccine
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Anhui Huaxin Medicinal Glass Products Co. Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Berlin Packaging LLC
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Corning Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 DWK Life Sciences GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Gerresheimer AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Jinan Youlyy Industrial Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 JOTOP Glass
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Richland Glass Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Schott AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 Shandong Pharmaceutical Glass Co. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Stevanato Group
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report